Repligen Rg
RGEN
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
08/30/2025 - 02:00:00
Bid
08/29/2025 - 21:59:59
Bid
Volume
Ask
08/29/2025 - 21:59:59
Ask
Volume
122.32
+0.15 ( +0.12% )
122.31
100
122.37
900
More information
Analysis by TheScreener
29.08.2025
Evaluation Slightly negative  
Interest Very weak  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 01.07.2025.
Interest
  Very weak
One star since 26.08.2025.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 19.08.2025 at a price of 123.50.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 15.08.2025.
4wk Rel Perf
  -3.78%
 
The four-week dividend-adjusted underperformance versus SP500 is 3.78%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.64%.
Mkt Cap in $bn
  6.88
With a market capitalization between $2 & $8bn, REPLIGEN is considered a mid-cap stock.
G/PE Ratio
  0.81
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  43.35
The estimated PE is for the year 2027.
LT Growth
  34.96%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  122
For 1% of index variation, the stock varies on average by 1.22%.
Correlation
  0.49
49.03% of stock movements are explained by index variations.
Value at Risk
  48.31
The value at risk is estimated at USD 48.31. The risk is therefore 39.49%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  22.11.2019